Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05965349 · ClinicalTrials.gov registry record · NA

MBCT Intervention: Healthy Mind, Healthy Living

A NA study, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
24
Enrollment target

NCT05965349: Completed NA study, sponsored by University of Washington.

NCT05965349 is a NA study that has completed, run by University of Washington. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05965349, a NA study, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

Depression among older Korean Americans are rising. Mindfulness-based cognitive therapy (MBCT) is an evidence-based intervention (EBI), effective for preventing depression relapse and reducing depressive symptoms. To enhance feasibility, acceptability, and reach, a brief version of MBCT has been developed and delivered by telephone (brief MBCT-T), but has only been tested in primarily White samples. This study will test test the effect of brief MBCT-T among older Korean Americans.

Primary Outcome

Quick Inventory of Depressive Symptomatology (QIDS-SR); score ranges from 0-27 with higher scores indicating more depressive symptoms.

Interventions

  • BEHAVIORAL Healthy Mind, Healthy Living

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2023-04-03
Est. Completion 2024-12-31
Phase NA
University of Washington

1,048 total trials

What the finished NCT05965349 record still lists

NCT05965349 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Healthy Mind, Healthy Living is the first listed.

NCT05965349 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05965349 about?

NCT05965349 is a clinical study titled "MBCT Intervention: Healthy Mind, Healthy Living". Depression among older Korean Americans are rising. Mindfulness-based cognitive therapy (MBCT) is an evidence-based intervention (EBI), effective for preventing depression relapse and reducing depressive symptoms. To enhance feasibility, acceptability, and reach, a brief version of MBCT has been dev...

What is the current status of trial NCT05965349?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2023-04-03. Estimated completion is 2024-12-31.

What interventions are being tested in trial NCT05965349?

The interventions under investigation include: Healthy Mind, Healthy Living (BEHAVIORAL).

Who is sponsoring clinical trial NCT05965349?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05965349's enrollment target sits among peer trials

24 1736th of 2000 higher than 246 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05965349, the US trial registry maintained by the National Library of Medicine. NCT05965349 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.